Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Henry Niman who wrote (16559)	3/5/1998 4:00:00 PM
From: buyhiman	Read Replies (2) \| Respond to of 32384

I can claim bragging rights as an owner of Elan for 10+ years and many $$$ of profit and still growing. I expect to hold lgnd at least 5. Elan is very astute drug delivery company which acquired Athena in 96 or 97. They now have 2-3 seizure drugs on market some as controlled release forms. If neurological disorders can be linked to hormonal disorders/changes then seems ligand technology may have a role to play. Outside of cancer and heart disease, there are no harder nuts to crack than the neurological ones; alzheimers, stroke damage etc. etc. Would be nice to hear what Lgnd might offer at least theoretically in some of these unmet areas Carl R.